Trials / Unknown
UnknownNCT04107584
Prognostic Value of Plasma Biomarkers Among Patients With Hypertension
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 600 (estimated)
- Sponsor
- Beijing Institute of Heart, Lung and Blood Vessel Diseases · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Hypertension is the most important risk factor for cardiovascular and cerebrovascular diseases，and also a substantial public health problem. The purpose of the study is to investigate the association between plasma biomarkers and adverse outcomes in patients with hypertension.
Conditions
Timeline
- Start date
- 2017-04-01
- Primary completion
- 2022-08-01
- Completion
- 2022-08-01
- First posted
- 2019-09-27
- Last updated
- 2019-09-27
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04107584. Inclusion in this directory is not an endorsement.